510(k) · Cleared
ClearedPALACOS R, PALACOS R pro, PALACOS R+G, PALACOS R+G pro, PALACOS MV+G
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Heraeus Medical GmbH · LOD Bone Cement
Cleared on Nov 23, 2020 as substantially equivalent to K030902 (Heraeus Kulzer GmbH & Co. KG, 2003) and 4 other predicates after an 87-day review. Its family tree reaches back 3 generations to 1984. 3 later devices descend from it.
- Decided
- Nov 23, 2020
- Review
- 87 days
- Class
- Class II
- Product code
- LOD
- Recalls
- None
- Predicates
- 5
Its longest line of descent runs back 3 generations to P810020 (1984). 6 ancestors in all. 3 later devices descend from it, 2 citing it directly.
- Root · 3 generations backP810020 Palacos R Bone CementSmith & Nephew Richards, Inc. · 1984 · Recalled
- 2 generations backK031673 Refobacin -Palacos GHeraeus Kulzer GmbH & Co. KG · 2004 · Recalled
- 1 generation backK142157 Palacos R+G ProHeraeus Medical GmbH · 2014
- This deviceK202475 PALACOS R, PALACOS R pro, PALACOS R+G, PALACOS R+G pro, PALACOS MV+GHeraeus Medical GmbH · 2020
- Descendant · cites it directly · 1 of its ownK210607 PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proHeraeus Medical GmbH · 2021 · Recalled
- Descendant · cites it directly · 0 of its ownK211869 OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A…Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · 2022
- Descendant · 2 generations on · 0 of its ownK213812 PALACOS MV proHeraeus Medical GmbH · 2022 · Recalled
Most influential descendants
Showing 3 of 3 · See all- K210607PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proHeraeus Medical GmbH · 2021 · cites it directly1descendant
- K211869OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A Polymethylmethacrylate (PMMA)…Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · 2022 · cites it directly0descendants
- K213812PALACOS MV proHeraeus Medical GmbH · 2022 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | P810020 | Palacos R Bone Cement | Smith & Nephew Richards, Inc. | 1984 | 1 |
| −2 | K031673 | Refobacin -Palacos G | Heraeus Kulzer GmbH & Co. KG | 2004 | 1 |
| −1 | K142157 | Palacos R+G Pro | Heraeus Medical GmbH | 2014 | — |
| 0 (this device) | K202475 | PALACOS R, PALACOS R pro, PALACOS R+G, PALACOS R+G pro, PALACOS MV+G | Heraeus Medical GmbH | 2020 | — |
| +1 | K210607 | PALACOS R pro, PALACOS R+G pro, PALACOS MV+G pro | Heraeus Medical GmbH | 2021 | 6 |
| +1 | K211869 | OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A Polymethylmethacrylate… | Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE | 2022 | — |
| +2 | K213812 | PALACOS MV pro | Heraeus Medical GmbH | 2022 | 2 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 1 | 0 |
| 2005 | 1 | 0 |
| 2015 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2021 | 1 | 0 |
| 2022 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LOD device
- #1 K254107 Refobacin Bone Cement R (110034355)score 11.8 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (5)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K030902 | Palacos RSummary page 9…LACOS® R+G pro, PALACOS® R+G, PALACOS® MV+G Subsequent Product Code(s): KIH, JDZ III. PREDICATE DEVICES PALACOS® R (K030902) PALACOS® R pro (K150119) PALACOS® G (K031673) PALACOS® R+G pro (K142157) PALAMED G (K050855) No reference devices were used in… | 2003 |
| * | K150119 | PALACOS R proSummary page 9…R+G, PALACOS® MV+G Subsequent Product Code(s): KIH, JDZ III. PREDICATE DEVICES PALACOS® R (K030902) PALACOS® R pro (K150119) PALACOS® G (K031673) PALACOS® R+G pro (K142157) PALAMED G (K050855) No reference devices were used in this submission. IV.… | 2015 |
| * | K031673 | Refobacin -Palacos GSummary page 9…MV+G Subsequent Product Code(s): KIH, JDZ III. PREDICATE DEVICES PALACOS® R (K030902) PALACOS® R pro (K150119) PALACOS® G (K031673) PALACOS® R+G pro (K142157) PALAMED G (K050855) No reference devices were used in this submission. IV. DEVICE DESCRIPT… | 2004 |
| * | K142157 | Palacos R+G ProSummary page 9…MV+G Subsequent Product Code(s): KIH, JDZ III. PREDICATE DEVICES PALACOS® R (K030902) PALACOS® R pro (K150119) PALACOS® G (K031673) PALACOS® R+G pro (K142157) PALAMED G (K050855) No reference devices were used in this submission. IV. DEVICE DESCRIPTION A bundled Traditional 5… | 2014 |
| * | K050855 | Palamed GSummary page 9…roduct Code(s): KIH, JDZ III. PREDICATE DEVICES PALACOS® R (K030902) PALACOS® R pro (K150119) PALACOS® G (K031673) PALACOS® R+G pro (K142157) PALAMED G (K050855) No reference devices were used in this submission. IV. DEVICE DESCRIPTION A bundled Traditional 510(k) submission is… | 2005 |
What descends from it? (3)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 36 years and passes through 3 companies; a new generation was cleared every 10.3 years on median.
- 2 of the 6 ancestors have a recall of any class.
- Of its descendants, K210607 (Heraeus Medical GmbH, 2021) has gone furthest, with 1 descendant of its own.
- 8 other devices also cite its predicate K030902.
How does its category compare?
All LOD devicesLOD Bone Cement: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.
FDA decisions per year · LOD
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LOD
277in 2022
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LOD
2in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LOD
355in 2025
MAUDE reports naming product code LOD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 78 |
| 2008 | 1 | — | 0 | 134 |
| 2009 | 3 | 103 | 0 | 170 |
| 2010 | 0 | — | 0 | 291 |
| 2011 | 0 | — | 0 | 428 |
| 2012 | 0 | — | 0 | 412 |
| 2013 | 2 | — | 0 | 501 |
| 2014 | 1 | — | 1 | 465 |
| 2015 | 4 | 138 | 0 | 529 |
| 2016 | 1 | — | 0 | 615 |
| 2017 | 3 | 96 | 4 | 817 |
| 2018 | 2 | — | 0 | 1,295 |
| 2019 | 4 | 90 | 0 | 2,307 |
| 2020 | 3 | 139 | 1 | 1,294 |
| 2021 | 4 | 95 | 0 | 782 |
| 2022 | 3 | 277 | 2 | 472 |
| 2023 | 2 | — | 0 | 475 |
| 2024 | 1 | — | 0 | 492 |
| 2025 | 1 | — | 0 | 355 |
| 2026 | 1 | — | 2 | — |
What is it indicated for?
PALACOS® R is indicated for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone. PALACOS® R pro is indicated for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone. PALACOS® R+G is indicated for use in the second stage of a two-stage revision for total joint arthroplasty after…
Read the full statement (133 words)
PALACOS® R is indicated for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.
PALACOS® R pro is indicated for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.
PALACOS® R+G is indicated for use in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.
PALACOS® R+G pro is indicated for use in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.
PALACOS® MV+G is indicated for use in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K202475 · printed Nov 6, 2026
Cite this page
510(k) Report. “K202475: PALACOS R, PALACOS R pro, PALACOS R+G, PALACOS R+G pro, PALACOS MV+G.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K202475
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026